Literature DB >> 21193033

Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.

Noelia A-González1, Antonio Castrillo.   

Abstract

The liver X receptors (LXRα and LXRβ) are members of the nuclear receptor family of transcription factors that play essential roles in the transcriptional control of lipid metabolism. LXRs are endogenously activated by modified forms of cholesterol known as oxysterols and control the expression of genes important for cholesterol uptake, efflux, transport, and excretion in multiple tissues. In addition to their role as cholesterol sensors, a number of studies have implicated LXRs in the modulation of innate and adaptive immune responses. Both through activation and repression mechanisms, LXRs regulate diverse aspects of inflammatory gene expression in macrophages. The ability of LXRs to coordinate metabolic and immune responses constitutes an attractive therapeutic target for the treatment of chronic inflammatory disorders. This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193033     DOI: 10.1016/j.bbadis.2010.12.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  41 in total

1.  Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages.

Authors:  Ilke Vermeulen; Mark Baird; Juma Al-Dulayymi; Muriel Smet; Jan Verschoor; Johan Grooten
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

2.  Effects of alfalfa saponin extract on mRNA expression of Ldlr, LXRα, and FXR in BRL cells.

Authors:  Xin-ping Liang; Dong-qiang Zhang; Yan-yan Chen; Rui Guo; Jie Wang; Cheng-zhang Wang; Ying-hua Shi
Journal:  J Zhejiang Univ Sci B       Date:  2015-06       Impact factor: 3.066

Review 3.  Regulation of leucocyte homeostasis in the circulation.

Authors:  Christoph Scheiermann; Paul S Frenette; Andrés Hidalgo
Journal:  Cardiovasc Res       Date:  2015-03-05       Impact factor: 10.787

4.  A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.

Authors:  Steven C Pugliese; Sushil Kumar; William J Janssen; Brian B Graham; Maria G Frid; Suzette R Riddle; Karim C El Kasmi; Kurt R Stenmark
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

Review 5.  Innate immune cells as homeostatic regulators of the hematopoietic niche.

Authors:  María Casanova-Acebes; Noelia A-González; Linnea A Weiss; Andrés Hidalgo
Journal:  Int J Hematol       Date:  2014-03-15       Impact factor: 2.490

6.  Frontline Science: Activation of metabolic nuclear receptors restores periodontal tissue homeostasis in mice with leukocyte adhesion deficiency-1.

Authors:  Tetsuhiro Kajikawa; Baomei Wang; Xiaofei Li; Hui Wang; Triantafyllos Chavakis; Niki M Moutsopoulos; George Hajishengallis
Journal:  J Leukoc Biol       Date:  2020-05-18       Impact factor: 4.962

7.  Rational application of macrophage-specific LXR agonists avoids the pitfalls of SREBP-induced lipogenesis.

Authors:  Jason A Magida; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

Review 8.  Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses.

Authors:  Michael R Elliott; Kyle M Koster; Patrick S Murphy
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

9.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 10.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.